Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-24-130184·ENZON PHARMACEUTICALS, INC.
Schedule 13D ownership disclosure
ENZON INC
Common Stock, No par value · CUSIP: 293904108
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CARL C ICAHNReported CIK 0000921669
Shares: 36,056,636.00 · Class: 48.6%
- ICAHN PARTNERS MASTER FUND LPReported CIK 0001322827
Shares: 14,923,911.00 · Class: 20.1%
- Icahn Offshore LPReported CIK 0001322825
Shares: 14,923,911.00 · Class: 20.1%
- Icahn Partners LPReported CIK 0001313666
Shares: 21,132,725.00 · Class: 28.5%
- Icahn Onshore LPReported CIK 0001322826
Shares: 21,132,725.00 · Class: 28.5%
- Icahn Capital LPReported CIK 0001412093
Shares: 36,056,636.00 · Class: 48.6%
- IPH GP LLCReported CIK 0001412091
Shares: 36,056,636.00 · Class: 48.6%
- ICAHN ENTERPRISES HOLDINGS L.P.Reported CIK 0001034563
Shares: 36,056,636.00 · Class: 48.6%
- ICAHN ENTERPRISES G.P. INC.Reported CIK 0001257324
Shares: 36,056,636.00 · Class: 48.6%
- BECKTON CORPReported CIK 0001080113
Shares: 36,056,636.00 · Class: 48.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-130184
- Form type
- SCHEDULE 13D/A
- Filer
- ENZON PHARMACEUTICALS, INC.
- CIK
- CIK 727510
- Filed
- Dec 19, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13D beneficial ownership